(Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion ...

The 15% tariff would be lower than previously threatened, but it would remain a high duty on America’s largest trading ...

Though the Trump administration and European Union have agreed to a deal that reduces planned U.S. tariffs, Mexico still ...

US tariffs have had a serious adverse effect on overall South Korean exports, an examination of data indicates. Goods subject to sectoral tariffs showed notable declines. In addition, the heavy ...

Trump is targeting China's transshipments through Southeast Asia. But can tariffs and trade agreements really curb China's ...

The construction market in the United States is expected to be the most impacted by tariff policies and will slow throughout ...

The announcement and anticipation of US tariffs have already had an immediate and devastating impact on trade performance.

US President Donald Trump announced on Sunday that the United States was imposing 15-percent tariffs on all European Union countries.

Toy companies have been fretting about the impact of Trump's global tariff blitz on the industry, particularly when it comes ...

European companies face challenges with a new U.S. trade deal involving 15% import tariffs on EU goods. Key industries, ...

European companies were on edge on Monday as corporate leaders tried to unpick the real impact of a hard-won U.S. trade deal ...

Cipla's CEO addresses impact of US tariffs on pharmaceutical industry, remains optimistic about company's performance and ...